April 14, 2021
Business News

Vedanta Biosciences to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass.–()–Vedanta Biosciences, a leading clinical-stage microbiome company developing a new category of oral therapies using rationally defined bacterial consortia manufactured from clonal cell banks, today announced that members of its executive team will present and host one-on-one meetings at the following virtual investor conferences:

Chardan 3rd Annual Microbiome Medicines Summit

Date: Monday, March 8, 2021

Presentation Time: 2:00 PM ET

H.C. Wainwright Global Life Sciences Conference

Date: Tuesday, March 9, 2021

Presentation Time: 7:00 AM ET

Credit Suisse 2021 Healthcare Innovators Series: Life Sciences Private Company Event

Date: Thursday, March 11, 2021

Presentation Time: 12:20 PM ET


Click here to view the original article.

Related Posts

You might also like ...

Minnesota Department of Transportation Leverages Iteris’ ClearMobility Cloud for Improved Statewide Mobility
Bundesgerichtshof entscheidet zu Gunsten von Solvay im Patentstreit mit Neo
Fraunhofer and Sinclair to Collaborate Towards Integrating Digital Radio Mondiale Framework into the ATSC 3.0 Digital TV Platform